Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "P01B" (14)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Hydroxychloroquine (P01BA02) 2 products
WHO-DDD
DrugBank.ca
L
IP
CI
Plaquenil
30 Tablet(s)
3.13
12.60
10 %
Coated tablets: Hydroxychloroquini Sulfas 200 mg
Sanofi-Aventis
(Suisse) SA
B / SL / SO
FB
G
L
IP
CI
CM
Hydroxychloroquine
Zentiva
30 Tablet(s)
2.66
12.15
10 %
Coated tablets: Hydroxychloroquini Sulfas 200 mg
Helvepharm AG
B / SL / SG
FB
G
Proguanil and Atovaquone (P01BB51) 7 products
WHO-DDD
DrugBank.ca
L
IP
CI
Malarone
‐
I
-
T
12 Tablet(s)
22.30
40.45
10 %
Coated tablets: 2 Active Agents
GlaxoSmithKline AG
A / SL / SO
FB
G
L
IP
CI
Atovaquon Plus Spirig HC
12 Tablet(s)
18.95
37.05
10 %
Coated tablets: 2 Active Agents
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
CI
Atovaquon-Proguanil-Mepha 250 / 100
12
18.95
37.05
10 %
Coated tablets: 2 Active Agents
Mepha Pharma AG
A / SL / SG
FB
G
IP
CI
Atovaquon Plus Spirig HC
24
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
A
FB
G
IP
CI
Atovaquon-Proguanil-Mepha
Junior 62.5 / 25
12
k.A.
Coated tablets: 2 Active Agents
Mepha Pharma AG
A
FB
G
IP
CI
Atovaquon-Proguanil-Mepha 250 / 100
24
k.A.
Coated tablets: 2 Active Agents
Mepha Pharma AG
●
A
FB
G
IP
CI
Malarone Junior
12
k.A.
Coated tablets: 2 Active Agents
GlaxoSmithKline AG
A
FB
G
Mefloquine (P01BC02) 1 products
WHO-DDD
DrugBank.ca
IP
CI
Mephaquin
‐
I
8 Tablet(s)
k.A.
Coated tablets: Mefloquinum 250 mg
Mepha Pharma AG
A
FB
G
Pyrimethamine (P01BD01) 1 products
WHO-DDD
DrugBank.ca
L
IP
CI
Daraprim
-
T
30
13.48
31.10
10 %
Tablets: Pyrimethaminum 25 mg
GlaxoSmithKline AG
B / SL
FB
G
Artemether and Lumefantrine (P01BF01) 3 products
WHO-DDD
DrugBank.ca
L
IP
CI
Riamet 20 mg/120 mg
24 Tablet(s)
25.56
44.20
10 %
Tablets: 2 Active Agents
Novartis Pharma
Schweiz AG
A / SL
FB
G
L
IP
CI
Riamet Dispersible
12
12.78
30.30
10 %
Tablets: 2 Active Agents
Novartis Pharma
Schweiz AG
A / SL
FB
G
IP
Riamet Baby
12
k.A.
Tabletten zur Herstellung einer Suspension zum Einnehmen: 2 Active Agents
Novartis Pharma
Schweiz AG
A
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home
